Insider Activity to Watch: Vystar Corp $VYST

annual-report-203760_1920

Vystar Corp (OTCPK:VYST) insider have most recently took part in a trading activity. On Jun 16, 2017 Allegra Joseph, 10% Owner bought 10,000 shares having total worth of $1,000 at the price of $0.1 per share, following the transaction a total of 12,293,843 shares owned by Allegra Joseph. Before this latest buy, Allegra Joseph purchased VYST at 13 other times during the past twelve months, for a total investment of $63,610 at an average of $0.14 per share.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 29 times by insiders. an employee of the company was the buyer in 29 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 0 %
12 Month 29 0 %

Vystar Corporation is a Georgia corporation that was incorporated in 2003. The Company is an owner of the technology to produce Vytex Natural Rubber Latex (NRL). This technology reduces antigenic protein in natural rubber latex products made with Vytex to virtually undetectable levels. The allergic reactions to untreated latex are a significant detriment affecting numerous individuals globally that use many different products made with NRL. Vytex NRL is produced at the latex processor level and can be easily integrated into the current processing environments without additional capital equipment investment. The protein removal and modification process that leads to Vytex NRL allows manufacturers to lower manufacturing costs with the benefit of reduced protein levels. Through its Toll Manufacturing Agreement with Revertex, the concentrated Vytex NRL is produced by Revertex for a fee and it is responsible for marketing and selling it. Under its second model, the processor can contract to market and sell a proprietary version of Vytex NRL in a pre-vulcanized form. In the United States, healthcare and many food and food-based packaging products are subject to regulation by the Food and Drug Administration.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.